文献速递生殖医学

辅助生殖技术孕育的儿童和年轻成年人的癌症风险

Risk of cancer in children and young adults conceived by assisted reproductive technology.
PubMed 文献 · Hum Reprod · 2019-01-01

这项全国性历史队列研究纳入1980至2001年间接受不孕治疗的女性所生活产子代,中位随访21年,比较辅助生殖技术(ART)孕育儿童与自然孕育儿童的癌症风险。总体癌症风险未见升高(HR 1.00,95%CI 0.72-1.38;SIR 1.11,95%CI 0.90-1.36),但部分亚组风险非显著升高,且需要更大样本和更长随访研究。

要点

  • ART孕育儿童总体癌症风险与自然孕育儿童相比无显著差异(HR 1.00,95%CI 0.72-1.38)。
  • ICSI或冷冻保存孕育儿童癌症风险非显著升高(HR分别为1.52和1.80)。
  • 作者认为需更大样本和更长随访研究来探究成人及ICSI/冷冻胚胎子代的癌症风险。

核心结论

  • 总体上,ART孕育儿童在中位随访21年后未显现癌症风险升高。

研究设计与样本

  • 全国性历史队列研究,前瞻性随访(中位21年),纳入1980至2001年间接受不孕治疗女性所生的所有活产子代。
  • 共47 690名活产儿童,其中24 269名为ART孕育,13 761名为自然孕育,9 660名经自然或促排卵药物但非ART孕育。

主要发现

  • ART孕育儿童与不孕女性自然孕育儿童相比,总体癌症风险无显著差异(HR 1.00,95%CI 0.72-1.38);与一般人群相比亦无显著差异(SIR 1.11,95%CI 0.90-1.36)。
  • 18岁及以上人群中,ART孕育者与自然孕育者相比癌症HR为1.25(95%CI 0.73-2.13)。
  • ICSI孕育儿童癌症风险HR为1.52(95%CI 0.81-2.85),冷冻保存孕育儿童HR为1.80(95%CI 0.65-4.95),均未达统计学显著。
  • ART孕育儿童与自然孕育儿童相比,淋巴母细胞白血病HR为2.44(95%CI 0.81-7.37),黑色素瘤HR为1.86(95%CI 0.66-5.27),均未达统计学显著。

临床怎么用

  • 作者认为这项大型研究结果可使医生更好地告知考虑ART的夫妇关于其子代长期安全性的信息。
  • 作者认为需要更大样本和更长随访的研究来探究成人以及ICSI和/或冷冻胚胎孕育儿童的癌症风险。

局限性

  • 尽管队列规模大且随访时间长,但儿童和年轻成人癌症罕见,癌症数量较少,限制了亚组分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Do children conceived by ART have an increased risk of cancer? SUMMARY ANSWER: Overall, ART-conceived children do not appear to have an increased risk of cancer. WHAT IS KNOWN ALREADY: Despite the increasing use of ART, i.e. IVF or ICSI worldwide, information about possible long-term health risks for children conceived by these techniques is scarce. STUDY DESIGN, SIZE, DURATION: A nationwide historical cohort study with prospective follow-up (median 21 years), including all live-born offspring from women treated with subfertility treatments between 1980 and 2001. PARTICIPANTS/MATERIALS, SETTING, METHODS: All offspring of a nationwide cohort of subfertile women (OMEGA study) treated in one of the 12 Dutch IVF clinics or two fertility clinics. Of 47 690 live-born children, 24 269 were ART-conceived, 13 761 naturally conceived and 9660 were conceived naturally or through fertility drugs, but not by ART. Information on the conception method of each child and potential confounders were collected through the mothers' questionnaires and medical records. Cancer incidence was ascertained through linkage with The Netherlands Cancer Registry from 1 January 1989 until 1 November 2016. Cancer risk in ART-conceived children was compared with risks in naturally conceived children from subfertile women (hazard ratios [HRs]) and with the general population (standardized incidence ratios [SIRs]). MAIN RESULTS AND THE ROLE OF CHANCE: The median follow-up was 21 years (interquartile range (IQR): 17-25) and was shorter in ART-conceived children (20 years, IQR: 17-23) compared with naturally conceived children (24 years, IQR: 20-30). In total, 231 cancers were observed. Overall cancer risk was not increased in ART-conceived children, neither compared with naturally conceived children from subfertile women (HR: 1.00, 95% CI 0.72-1.38) nor compared with the general population (SIR = 1.11, 95% CI: 0.90-1.36). From 18 years of age onwards, the HR of cancer in ART-conceived versus naturally conceived individuals was 1.25 (95% CI: 0.73-2.13). Slightly but non-significantly increased risks were observed in children conceived by ICSI or cryopreservation (HR = 1.52, 95% CI: 0.81-2.85; 1.80, 95% CI: 0.65-4.95, respectively). Risks of lymphoblastic leukemia (HR = 2.44, 95% CI: 0.81-7.37) and melanoma (HR = 1.86, 95% CI: 0.66-5.27) were non-significantly increased for ART-conceived compared with naturally conceived children. LIMITATIONS, REASONS FOR CAUTION: Despite the large size and long follow-up of the cohort, the number of cancers was rather small for subgroup analyses as cancer in children and young adults is rare. WIDER IMPLICATIONS OF THE FINDINGS: Overall, ART-conceived children do not appear to have an increased cancer risk after a median follow-up of 21 years. This large study provides important results, enabling physicians to better inform couples considering ART about the long-term safety of ART for their children. However, larger studies with prolonged follow-up are needed to investigate cancer risk in adults and in children conceived by ICSI and/or from cryopreserved embryos. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by The Dutch Cancer Society (NKI 2006-3631) which funded the OMEGA-women's cohort and Children Cancer Free (KIKA;147) which funded the OMEGA-offspring cohort. We declare no competing interests.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Spaan M, van den Belt-Dusebout AW, van den Heuvel-Eibrink MM, et al. Risk of cancer in children and young adults conceived by assisted reproductive technology. Hum Reprod. 2019. PMID: 30715305. doi:10.1093/humrep/dey394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。